Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Cian Healthcare Merger & Restructuring

Cian Healthcare disposed of its Dr. Smiths Biotech subsidiary under an NCLT-approved resolution plan. Its equity was cancelled with nil consideration receivable.

Source

BSE filing, BSE: 542678. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Cian Healthcare Ltd: key numbers

Share price
₹32.20
Market cap
₹80.50 Cr
Revenue (annual)
₹28.30 Cr
Net profit (annual)
₹-23.29 Cr
Promoter holding
95.00%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Cian Healthcare Ltd

All →

Other merger & restructuring announcements

All →
19:53 IST NSE
Merger & RestructuringEmkay Global Financial Services Ltd EMKAY

Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr

Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.

Value
₹30.00 Cr
Execution
Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals